The goal of CD Genomics is to empower scientists to make scientific breakthroughs in life science research, human genetics, disease relationships, drug discovery, diagnosis, disease treatment and biotechnology through bioinformatics data analysis.More Info
CD Genomics is a high-tech enterprise. Based on functional genomics BT+IT (high-throughput gene sequencing technology, biological information technology, high-performance biological cloud computing technology) technology, the company provides customers with next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. It has a R&D team with doctors and masters as the main body.
As a pioneer in biotechnology, CD Genomics has grown into one of the world's largest independent biotechnology companies, has reached many researchers and partners around the world, and is developing more products and services with breakthrough potential. As we serve more and more customers in different countries, we will continue to expand our business to other countries. And we are simultaneously developing the most powerful pipeline in our history. Our research business covers many countries and is headquartered in New York, USA.
About CD Genomics
CD Genomics is committed to providing quality services to customers through data mining, development, and standardized data analysis processes.
Provide continuous and satisfactory assistance to customers in the fields of life science research, pharmaceutical research and biotechnology. By mining the mysteries in biological data, it lays the foundation for basic research in life sciences.
About CD Genomics
The bioinformatics analysis platform of CD Genomics is a leading open solution for data-driven innovation aimed at discovering hidden potential in biological data, tapping new insights related to life science research or predicting new prospects.
Extensive scientific research through our bioinformatics analysis platform can raise scientific research capabilities to a new level.